Karbe Frank

Phathom Pharmaceuticals, Inc. · Director

Karbe Frank is listed in public filings as director. This Karbe Frank insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Phathom Pharmaceuticals, Inc. (PHAT), and Cidara Therapeutics, Inc. (CDTX). Investors use Karbe Frank's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Phathom Pharmaceuticals, Inc.PHAT$99k12.5k sharesBuyDec 13, 2024$7.93--